Immunoprecise Antibodies Stock Price on March 25, 2021
| IPA Stock | USD 1.26 0.02 1.61% |
Below is the normalized historical share price chart for Immunoprecise Antibodies extending back to December 04, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunoprecise Antibodies stands at 1.26, as last reported on the 19th of April, with the highest price reaching 1.28 and the lowest price hitting 1.21 during the day.
If you're considering investing in Immunoprecise Stock, it is important to understand the factors that can impact its price. Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of -0.021, which attests that the entity had a -0.021% return per unit of risk over the last 3 months. Immunoprecise Antibodies exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunoprecise Antibodies' Standard Deviation of 5.93, market risk adjusted performance of (0.08), and Risk Adjusted Performance of (0.01) to validate the risk estimate we provide.
At present, Immunoprecise Antibodies' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 30.1 M, whereas Common Stock Total Equity is forecasted to decline to about 53.9 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.02, whereas Price To Sales Ratio is forecasted to decline to 89.68. Immunoprecise Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of January 2017 | 200 Day MA 1.8039 | 50 Day MA 1.6713 | Beta 0.33 |
Immunoprecise |
Sharpe Ratio = -0.021
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IPA |
Estimated Market Risk
| 5.96 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immunoprecise Antibodies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunoprecise Antibodies by adding Immunoprecise Antibodies to a well-diversified portfolio.
Price Book 0.9416 | Enterprise Value Ebitda (3.71) | Price Sales 1.5114 | Shares Float 22.8 M | Wall Street Target Price 6.92 |
Immunoprecise Antibodies Valuation on March 25, 2021
It is possible to determine the worth of Immunoprecise Antibodies on a given historical date. On March 25, 2021 Immunoprecise was worth 5.09 at the beginning of the trading date compared to the closed value of 5.68. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunoprecise Antibodies stock. Still, in general, we apply an absolute valuation method to find Immunoprecise Antibodies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunoprecise Antibodies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunoprecise Antibodies' related companies.
| Open | High | Low | Close | Volume | |
04/04/2022 | 5.09 | 5.75 | 5.09 | 5.68 | 58,949 |
| 5.74 | 6.04 | 5.74 | 5.78 | 28,926 |
| Backtest Immunoprecise Antibodies | | | Immunoprecise Antibodies History | | | Immunoprecise Antibodies Valuation | Next |
Immunoprecise Antibodies Trading Date Momentum on March 25, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Immunoprecise Antibodies Fundamentals Correlations and Trends
By evaluating Immunoprecise Antibodies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunoprecise Antibodies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunoprecise financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunoprecise Antibodies Stock history
Immunoprecise Antibodies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunoprecise is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunoprecise Antibodies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunoprecise Antibodies stock prices may prove useful in developing a viable investing in Immunoprecise Antibodies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 28.6 M | 30.1 M | |
| Net Loss | -23.9 M | -22.7 M |
Immunoprecise Antibodies Stock Technical Analysis
Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunoprecise Antibodies Period Price Range
Low | April 4, 2022
| High |
5.09 | 5.68 |
Immunoprecise Antibodies April 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By undertsting and applying Immunoprecise Antibodies stock market strength indicators, traders can identify Immunoprecise Antibodies entry and exit signals to maximize returns
| Accumulation Distribution | 6766.32 | |||
| Daily Balance Of Power | 0.8939 | |||
| Rate Of Daily Change | 1.12 | |||
| Day Median Price | 5.42 | |||
| Day Typical Price | 5.51 | |||
| Price Action Indicator | 0.55 | |||
| Period Momentum Indicator | (4.42) |
Immunoprecise Antibodies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunoprecise Antibodies' price direction in advance. Along with the technical and fundamental analysis of Immunoprecise Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunoprecise to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunoprecise Antibodies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.939 | Quarterly Revenue Growth 0.203 | Return On Assets (0.11) | Return On Equity (0.26) |
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunoprecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.